We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
AUM
$499M
AUM Growth
-$99.5M
Cap. Flow
-$132M
Cap. Flow %
-26.33%
Top 10 Hldgs %
40.92%
Holding
243
New
104
Increased
7
Reduced
5
Closed
82

Sector Composition

Rank Sector Weight
1 Financials 22.3%
2 Technology 16.74%
3 Healthcare 11.05%
4 Industrials 10.4%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COCH icon
101
Envoy Medical
COCH
$51.7M
$973K 0.19%
+99,996
New +$972K
VLTA
102
DELISTED
Volta Inc.
VLTA
$971K 0.19%
96,800
CTAQ
103
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$971K 0.19%
100,000
SLCR
104
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$965K 0.19%
+100,000
New +$972K
OPA
105
DELISTED
Magnum Opus Acquisition Limited
OPA
$962K 0.19%
+100,000
New +$970K
PIIIW icon
106
P3 Health Partners Inc Warrant
PIIIW
$130K
$923K 0.18%
+93,333
New +$95.1K
AEON icon
107
AEON Biopharma
AEON
$12.9M
$861K 0.17%
+1,240
New +$867K
IIAC
108
DELISTED
Investindustrial Acquisition Corp.
IIAC
$831K 0.17%
85,165
MSPRZ
109
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$789K 0.16%
79,971
SDST
110
Stardust Power Inc
SDST
$5.71M
$781K 0.16%
+8,000
New +$785K
AAC
111
DELISTED
Ares Acquisition Corporation
AAC
$780K 0.16%
+80,000
New +$785K
LIDR icon
112
AEye
LIDR
$52.8M
$766K 0.15%
2,547
JCICW
113
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$744K 0.15%
+77,024
New +$52.8K
GIGGW
114
DELISTED
GigCapital4, Inc. Warrant
GIGGW
$657K 0.13%
+66,665
New +$62.3K
MBAC.WS
115
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$648K 0.13%
+66,666
New +$55.8K
PL icon
116
Planet Labs
PL
$7.3B
$602K 0.12%
+61,618
New +$608K
ANAC.WS
117
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$587K 0.12%
+60,295
New +$51.5K
APGB.WS
118
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$584K 0.12%
+59,998
New +$64.5K
FAZEW
119
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$562K 0.11%
+57,666
New +$58.5K
CPTK.WS
120
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
$554K 0.11%
+57,298
New +$42K
PRPC.WS
121
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$542K 0.11%
+55,459
New +$62.7K
ATIP
122
DELISTED
ATI Physical Therapy, Inc.
ATIP
$540K 0.11%
1,131
-4,020
-78% -$1.99M
FTAA
123
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$530K 0.11%
+53,792
New +$531K
PAYO icon
124
Payoneer
PAYO
$2.42B
$519K 0.1%
+50,000
New +$526K
JUGGU
125
DELISTED
Jaws Juggernaut Acquisition Corporation Unit
JUGGU
$503K 0.1%
+50,000
New +$503K

Similar funds

Athos Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Athos Capital held 243 positions worth $499M, down 17% from $599M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Athos Capital withdrew a net $132M in Q2 2021, closing 82 positions and reducing 5 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Athos Capital opened a new position in Xilinx Inc worth $26.7M.

  • Athos Capital's largest Q2 2021 buy was Xilinx Inc: 184,800 shares worth $26.7M.
  • Athos Capital added most to Kansas City Southern in Q2 2021, an estimated $14.9M increase.
  • Athos Capital's biggest Q2 2021 reduction was DouYu International Holdings, cutting an estimated $10.5M.
  • Athos Capital fully exited China Biologic Products Holdings, Inc. in Q2 2021, selling an estimated $110M.
  • Athos Capital's ten largest holdings make up 41% of its $499M portfolio in Q2 2021.
  • Athos Capital opened 104 new positions and closed 82 in Q2 2021.
  • Athos Capital's portfolio value fell 17% quarter-over-quarter to $499M.

Based on Athos Capital's 13F filing for Q2 2021, filed 12 Aug 2021.